Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II
about
Prognostic implication of cardiac troponin T increase following stent implantation.Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease.Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable riskQ10 supplementation effects on cardiac enzyme CK-MB and troponin in patients undergoing coronary artery bypass graft: a randomized, double-blinded, placebo-controlled clinical trialThe effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions.Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).Periprocedural myocardial injury in chronic total occlusion percutaneous interventions: a systematic cardiac biomarker evaluation study.Pharmacological prevention of peri-, and post-procedural myocardial injury in percutaneous coronary intervention.Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary interventionMyocardial ischemia is a key factor in the management of stable coronary artery diseaseSuppression of Myocardial Injury Markers following Percutaneous Coronary Interventions by Pre-treatment with Carvedilol.GPIIb/IIIa Receptor Antagonism Using Small Molecules Provides no Additive Long-Term Protection after Percutaneous Coronary Intervention as Compared to Clopidogrel Plus Aspirin.Was it a heart attack? Troponin measurement is not straightforward.Serum Creatine Kinase-MB Isoenzyme Activity among Subjects with Uncomplicated Essential Hypertension: Any Sex Differences.Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention.
P2860
Q35579996-E6ACF65E-5DDA-4037-A747-E8AF78D0E593Q35584631-A83A8DD8-E9FF-45FB-9530-D69984A41979Q35770964-5CC5A150-85A3-422D-B5B2-3EB3C6EB6DD6Q36785446-9B81032C-266B-40A0-815B-EE548292041CQ37145715-4269AA12-46E8-401D-9378-ED0B806B6127Q37472971-86558DF8-9F02-4F3F-AC23-9CCFC4ED1C6FQ37590053-132E2A7D-3586-4043-BBCB-12A0FBBB0270Q37638256-3EE1D15F-E296-4EC9-8BDD-5CF15069DAA6Q37680603-E470C792-1419-49DE-A45F-CD89B2E15001Q37722766-1DF303A5-5153-4B86-8F83-5FE0A29960F0Q38764160-AF975E50-5FBA-41E7-B3F6-C6952C4C3FE0Q42415858-747C70E4-11AB-473D-BA90-4E19ED9D7B57Q42777890-10F678EF-0FE2-4B60-BE43-B8029FFB500CQ43297579-FE05EC57-93C7-44A4-8905-141BBB374E3AQ49221091-393099EE-6AED-48B6-9DFB-DA44CC5966D4
P2860
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Clinical outcomes after detect ...... ion and Coronary Thrombosis-II
@ast
Clinical outcomes after detect ...... ion and Coronary Thrombosis-II
@en
Clinical outcomes after detect ...... ion and Coronary Thrombosis-II
@nl
type
label
Clinical outcomes after detect ...... ion and Coronary Thrombosis-II
@ast
Clinical outcomes after detect ...... ion and Coronary Thrombosis-II
@en
Clinical outcomes after detect ...... ion and Coronary Thrombosis-II
@nl
prefLabel
Clinical outcomes after detect ...... ion and Coronary Thrombosis-II
@ast
Clinical outcomes after detect ...... ion and Coronary Thrombosis-II
@en
Clinical outcomes after detect ...... ion and Coronary Thrombosis-II
@nl
P2093
P50
P1476
Clinical outcomes after detect ...... ion and Coronary Thrombosis-II
@en
P2093
B E Tardiff
J C Blankenship
J E Tcheng
K N Sigmon
K W Mahaffey
P S Teirstein
R A Harrington
P407
P577
1999-01-01T00:00:00Z